- Home
- Clinical Trials
- MitraClip device for patients at moderate risk for surgery
MitraClip device for patients at moderate risk for surgery
- Trial ID:
- IRB-20-7647
- Matthew J Price, M.D.
Inclusion Criteria
- Must be 18 years old or older
- Must be at moderate surgical risk for mitral valve repair
- Must have severe mitral regurgitation
- Be willing to participate in the trial for 10 years
Exclusion Criteria
- Current participating in another clinical investigation
- Secondary mitral regurgitation
- Severe tricuspid regurgitation
- A heart attack in the last year
- Severe valve disease
Additional Info
- The MitraClip device is currently approved by the FDA for patients who are at high-risk for traditional surgery, but is not approved for patients considered moderate to low surgical risk.
- All treatments and physician visits during this study will take place at Anderson Medical Pavilion, Scripps La Jolla. Study participation will last up to 10 years
Contact Info:
- Clinical Research Services
- CRSLeadership@scrippshealth.org